Terms: = Uterine cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
16 results:
1. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nacev BA; Sanchez-Vega F; Smith SA; Antonescu CR; Rosenbaum E; Shi H; Tang C; Socci ND; Rana S; Gularte-Mérida R; Zehir A; Gounder MM; Bowler TG; Luthra A; Jadeja B; Okada A; Strong JA; Stoller J; Chan JE; Chi P; D'Angelo SP; Dickson MA; Kelly CM; Keohan ML; Movva S; Thornton K; Meyers PA; Wexler LH; Slotkin EK; Glade Bender JL; Shukla NN; Hensley ML; Healey JH; La Quaglia MP; Alektiar KM; Crago AM; Yoon SS; Untch BR; Chiang S; Agaram NP; Hameed MR; Berger MF; Solit DB; Schultz N; Ladanyi M; Singer S; Tap WD
Nat Commun; 2022 Jun; 13(1):3405. PubMed ID: 35705560
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Characterization of Muellerian Tumors of the Urinary Tract.
Ortiz-Brüchle N; Wucherpfennig S; Rose M; Garczyk S; Bertz S; Hartmann A; Reis H; Szarvas T; Kiss A; Bremmer F; Golz R; Knüchel R; Gaisa NT
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200508
[TBL] [Abstract] [Full Text] [Related]
4. LPCAT1-tert fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.
Oliver GR; Marcano-Bonilla S; Quist J; Tolosa EJ; Iguchi E; Swanson AA; Hoppman NL; Schwab T; Sigafoos A; Prodduturi N; Voss JS; Knight SM; Zhang J; Fadra N; Urrutia R; Zimmerman M; Egan JB; Bilyeu AG; Jen J; Veras E; Al-Safi R; Block M; Kerr S; Fernandez-Zapico ME; Schoolmeester JK; Klee EW
PLoS One; 2021; 16(5):e0250518. PubMed ID: 34033669
[TBL] [Abstract] [Full Text] [Related]
5. Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and tert promoter mutations: A case report.
Cai JW; Chen XY; Chen JY; Wu ZY; Wu XY; Yu LH; You HH
Medicine (Baltimore); 2021 Apr; 100(13):e25346. PubMed ID: 33787635
[TBL] [Abstract] [Full Text] [Related]
6. A prospective study on the predictive value of DNA methylation in cervical intraepithelial neoplasia prognosis.
Guo Z; Hu Y; Yuan L; Li N; Wang T
Arch Gynecol Obstet; 2018 Sep; 298(3):589-596. PubMed ID: 29971561
[TBL] [Abstract] [Full Text] [Related]
7. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
8. Changes in Tumor Biology During Chemoradiation of Cervix cancer Assessed by Multiparametric MRI and Hypoxia PET.
Georg P; Andrzejewski P; Baltzer P; Daniel M; Wadsak W; Mitterhauser M; Sturdza A; Majercakova K; Karanikas G; Pötter R; Hacker M; Helbich T; Georg D; Pinker K
Mol Imaging Biol; 2018 Feb; 20(1):160-169. PubMed ID: 28540524
[TBL] [Abstract] [Full Text] [Related]
9. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.
Bokhari AA; Baker TM; Dorjbal B; Waheed S; Zahn CM; Hamilton CA; Maxwell GL; Syed V
Oncotarget; 2016 Oct; 7(43):69733-69748. PubMed ID: 27626172
[TBL] [Abstract] [Full Text] [Related]
10. Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.
Song Y; Hu B; Qu H; Wang L; Zhang Y; Tao J; Cui J
Oncotarget; 2016 Jun; 7(24):36154-36167. PubMed ID: 27166252
[TBL] [Abstract] [Full Text] [Related]
11. Heterogeneity of tert promoter mutations status in squamous cell carcinomas of different anatomical sites.
Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
[TBL] [Abstract] [Full Text] [Related]
12. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
Li PX; Mu JH; Xiao HL; Li DH
Oncol Rep; 2015 Jan; 33(1):125-32. PubMed ID: 25376180
[TBL] [Abstract] [Full Text] [Related]
13. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
Moore KN; Gold MA; McMeekin DS; Walker JL; Rutledge T; Zorn KK
Gynecol Oncol; 2008 Mar; 108(3):466-71. PubMed ID: 18191994
[TBL] [Abstract] [Full Text] [Related]
14. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma.
Harima Y; Nagata K; Harima K; Ostapenko VV; Tanaka Y; Sawada S
Int J Hyperthermia; 2001; 17(2):97-105. PubMed ID: 11252361
[TBL] [Abstract] [Full Text] [Related]
15. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
Harima Y; Nagata K; Harima K; Oka A; Ostapenko VV; Shikata N; Ohnishi T; Tanaka Y
Cancer; 2000 Jan; 88(1):132-8. PubMed ID: 10618615
[TBL] [Abstract] [Full Text] [Related]
16. Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.
Zhang L; Nadzan AM; Heyman RA; Love DL; Mais DE; Croston G; Lamph WW; Boehm MF
J Med Chem; 1996 Jul; 39(14):2659-63. PubMed ID: 8709094
[TBL] [Abstract] [Full Text] [Related]
